Mu‐Sheng Zeng

This paper designs a stable, high-affinity CR2 binder using deep learning to enhance B cell activation as a vaccine scaffold.

The paper develops a pipeline to identify glycoRNAs across the transcriptome, finding tRNAs and vtRNA2-1 as major glycosylated targets and discovering novel glycosylated long noncoding RNAs.

The paper identifies two EBV variants in BALF2 associated with increased NPC risk through genome sequencing and association studies in China.